Price changes over 2025 and 2026, tabulated and dated — does this still hold?

On Price changes, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the interesting bit.

If you can post the two or three numbers you are working from, several people here will check the arithmetic rather than argue about the conclusion.

Worth separating two things that post #12 runs together.

Two claims get bundled together under Price changes and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal one — this is why — usually is not.

Almost every disagreement in threads like this one dissolves once you say which of the two you are making.

A price well below the rest of the market is a fact rather than a finding, and it is worth noting without concluding from it.

Scoping that to what I have actually seen rather than what I have read.

Comparing a licensed product's price to a research-use-only preparation's price is comparing two different things, and the difference is most of the explanation.

Second-hand, so weight it accordingly.

This follows post #18 rather than contradicting it.

A cheaper option that arrives slowly has a cost in the form of running out, and people rarely price that.

Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen and a vial are not the same product and cannot be compared on price per milligram alone because dead volume, wastage, and number of doses actually obtainable differ.

Post #17 describes the usual case. This is about the unusual one.

List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an insurance company or pharmacy actually pays differ substantially. List price is not what anyone pays.

The most useful pricing posts here are the ones that show the arithmetic rather than the conclusion.

Someone should write this up properly, and it should probably not be me.

I would put moderate confidence on the mainstream reading of Price changes and no more. That is not scepticism for its own sake; it is where the sourcing actually stops.

Larger orders shift risk as well as price, because more of your material then comes from one lot.

Written in the hope of being told what I have missed.

Answering the question post #21 raises rather than the one it answers.

Answering the Price changes question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the first measurement was taken.

The arithmetic in post #25 is right; the assumption feeding it is the part to check.

On Price changes: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply here including this one.

Useful. I have added it to my own notes with the date on it.

Price variation between pharmacies: identical prescriptions can cost different amounts at different pharmacies because pharmacies negotiate individually with insurers and manufacturers.

That matches what I was told, which is not the same as knowing it.

For anyone finding this later: the short answer on Price changes is that it depends on one thing, and the rest of the thread is people identifying which thing.

Narrowing post #29, because the general version has more than one answer.

Price changes is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says which one is being asked for.